Impact of varicella vaccination in Argentina: Seroprevalence in children and adults in a pediatric hospital-Reference-Cited by-同舟云学术

Impact of varicella vaccination in Argentina: Seroprevalence in children and adults in a pediatric hospital

Published:2022-04 Issue: Volume:10 Page:100136
ISSN:2590-1362
Container-title:Vaccine: X
language:en
Short-container-title:Vaccine: X

Author:

Gentile Angela,del Valle Juarez María,Lucion María Florencia,Pejito María Natalia,Martínez Ana Clara,Folino Agostina,Viegas Mariana,Giglio Norberto

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference24 articles.

1. Evaluación de la efectividad de los programas de vacunación;Borràs;Gac Sanit,2011

2. Varicella and herpes zoster vaccines: WHO position paper, June 2014. Weekly epidemiological record. 20 JUNE 2014, 89th year / No. 25, 2014, 89, 265–288. http://www.who.int/wer.

3. American Academy of Pediatrics Varicella Zoster Virus Infections Kimberlin DW, Brady MT, Jackson MA, Long SS eds. Red Book 2018 Report of the Committee of Infectious Diseases 31st ed. Itasca; American Academy of Pediatrics; 2018. p. 869–79.

4. Time series analysis of the chickenpox rate and the impact of vaccine implementation in Tucumán;Barrenechea;Rev Argent Salud Pública,2020

5. Lineamientos Técnicos. Fundamentos de la Introducción 2015 de Vacuna contra Varicela al Calendario Nacional de Inmunizaciones. Ministerio de Salud. Presidencia de la Nacion.República Argentina. http://www.msal.gob.ar/images/stories/bes/graficos/0000000774cnt-2015-04_lineamientos-varicela.pdf [accessed 23 September 2020]. Ministerio de Salud de la Nación. Programa Nacional de Control de Enfermedades Inmunoprevenibles. Incorporación. Resolución 1029/2014. Buenos Aires: Boletín Official; 2014. Available from: https://www.argentina.gob.ar/normativa/nacional/resoluci%C3%B3n-1029-2014-232147/texto.